Bayer Aktiengesellschaft
54.68 EUR
−2.25% day
A German group selling prescription drugs, consumer medicines, seeds and crop chemicals, the last largely through Monsanto, bought in 2018. Lawsuits over its Roundup weedkiller have shaped its share price since.
Nov 19 · 54.68 EUR · +25.8% vs the window’s open
the numbers23
| when | value | change |
|---|---|---|
| Oct 20low | 43.48 EUR | |
| Oct 21 | 44.63 EUR | +2.6% |
| Oct 22 | 44.21 EUR | −0.9% |
| Oct 23 | 43.98 EUR | −0.5% |
| Oct 26 | 45.56 EUR | +3.6% |
| Oct 27 | 46.15 EUR | +1.3% |
| Oct 28 | 46.03 EUR | −0.3% |
| Oct 29 | 47.96 EUR | +4.2% |
| Oct 30 | 50.58 EUR | +5.5% |
| Nov 2 | 50.02 EUR | −1.1% |
| Nov 3 | 51.84 EUR | +3.6% |
| Nov 4 | 54.24 EUR | +4.6% |
| Nov 5 | 56.22 EUR | +3.7% |
| Nov 6 | 55.58 EUR | −1.1% |
| Nov 9 | 56.62 EUR | +1.9% |
| Nov 10high | 57.08 EUR | +0.8% |
| Nov 11 | 56.76 EUR | −0.6% |
| Nov 12 | 56.56 EUR | −0.4% |
| Nov 13 | 56.52 EUR | −0.1% |
| Nov 16 | 57.00 EUR | +0.8% |
| Nov 17 | 56.14 EUR | −1.5% |
| Nov 18 | 55.94 EUR | −0.4% |
| Nov 19latest | 54.68 EUR | −2.3% |
Lately
A US judge approved Bayer's $7.25bn class settlement of claims that Roundup's glyphosate caused non-Hodgkin lymphoma. It binds future claimants too, capping the liability bought with Monsanto in 2018, and pays sick users $10,000 to $165,000 each. The ruling came after the last close on the chart, so it does not explain the rise.